The safety and effectiveness of adenosine diphosphate receptor inhibitor pretreatment among acute myocardial infarction patients treated with percutaneous coronary intervention in community practice: Insights from the TRANSLATE-ACS study.
Mark B EffronTracy Y WangGregg C FonarowTimothy D HenryMarjorie E ZettlerBrian A BakerLisa A McCoyEric D PetersonPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2017)
ADP receptor inhibitor pretreatment (44%) is commonly used among acute MI patients undergoing PCI in contemporary practice, but no significant differences were found in in-hospital MACE and/or bleeding risks between patients receiving versus not receiving pretreatment, regardless of ADP receptor inhibitor type.
Keyphrases
- acute myocardial infarction
- percutaneous coronary intervention
- acute coronary syndrome
- healthcare
- patients undergoing
- coronary artery disease
- primary care
- st segment elevation myocardial infarction
- antiplatelet therapy
- st elevation myocardial infarction
- atrial fibrillation
- randomized controlled trial
- mental health
- systematic review
- left ventricular
- coronary artery bypass grafting
- binding protein
- quality improvement
- liver failure
- heart failure
- intensive care unit
- respiratory failure
- coronary artery bypass
- mechanical ventilation